Rainbow Childrens Medicare Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Finolex Industries Ltd, Sun Pharma Advanced Research Company Ltd, Bajaj Finserv Ltd, Finolex Cables Ltd are among the other stocks to see a surge in volumes on BSE today, 24 March 2025.

Rainbow Childrens Medicare Ltd notched up volume of 5.03 lakh shares by 10:48 IST on BSE, a 74.76 fold spurt over two-week average daily volume of 6733 shares. The stock rose 1.59% to Rs.1,322.70. Volumes stood at 8135 shares in the last session.

Finolex Industries Ltd registered volume of 5.35 lakh shares by 10:48 IST on BSE, a 7.07 fold spurt over two-week average daily volume of 75680 shares. The stock rose 11.14% to Rs.193.50. Volumes stood at 72661 shares in the last session.

Sun Pharma Advanced Research Company Ltd recorded volume of 14.8 lakh shares by 10:48 IST on BSE, a 3.61 times surge over two-week average daily volume of 4.09 lakh shares. The stock gained 1.18% to Rs.149.50. Volumes stood at 12.66 lakh shares in the last session.

Bajaj Finserv Ltd saw volume of 1.44 lakh shares by 10:48 IST on BSE, a 3.35 fold spurt over two-week average daily volume of 43121 shares. The stock increased 1.97% to Rs.1,882.00. Volumes stood at 47109 shares in the last session.

Finolex Cables Ltd saw volume of 1.06 lakh shares by 10:48 IST on BSE, a 2.39 fold spurt over two-week average daily volume of 44151 shares. The stock increased 12.08% to Rs.940.15. Volumes stood at 43016 shares in the last session.

Powered by Capital Market - Live News

Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024.

Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review.

Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year.

For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24.

For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY).

Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review.

On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26.

Rainbow Children’s Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds.

During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals

Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.”

Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds.

The scrip slipped 2.60% to Rs 1,347.05 on the BSE.

Powered by Capital Market - Live News

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024.

Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review.

Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year.

For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24.

For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY).

Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review.

On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26.

Rainbow Children’s Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds.

During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals

Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.”

Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds.

The scrip slipped 2.60% to Rs 1,347.05 on the BSE.

Powered by Capital Market - Live News

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 9 February 2025.

Powered by Capital Market - Live News

Finolex Industries Ltd, Sun Pharma Advanced Research Company Ltd, Bajaj Finserv Ltd, Finolex Cables Ltd are among the other stocks to see a surge in volumes on BSE today, 24 March 2025.

Rainbow Childrens Medicare Ltd notched up volume of 5.03 lakh shares by 10:48 IST on BSE, a 74.76 fold spurt over two-week average daily volume of 6733 shares. The stock rose 1.59% to Rs.1,322.70. Volumes stood at 8135 shares in the last session.

Finolex Industries Ltd registered volume of 5.35 lakh shares by 10:48 IST on BSE, a 7.07 fold spurt over two-week average daily volume of 75680 shares. The stock rose 11.14% to Rs.193.50. Volumes stood at 72661 shares in the last session.

Sun Pharma Advanced Research Company Ltd recorded volume of 14.8 lakh shares by 10:48 IST on BSE, a 3.61 times surge over two-week average daily volume of 4.09 lakh shares. The stock gained 1.18% to Rs.149.50. Volumes stood at 12.66 lakh shares in the last session.

Bajaj Finserv Ltd saw volume of 1.44 lakh shares by 10:48 IST on BSE, a 3.35 fold spurt over two-week average daily volume of 43121 shares. The stock increased 1.97% to Rs.1,882.00. Volumes stood at 47109 shares in the last session.

Finolex Cables Ltd saw volume of 1.06 lakh shares by 10:48 IST on BSE, a 2.39 fold spurt over two-week average daily volume of 44151 shares. The stock increased 12.08% to Rs.940.15. Volumes stood at 43016 shares in the last session.

Powered by Capital Market - Live News

Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024.

Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review.

Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year.

For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24.

For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY).

Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review.

On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26.

Rainbow Children’s Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds.

During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals

Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.”

Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds.

The scrip slipped 2.60% to Rs 1,347.05 on the BSE.

Powered by Capital Market - Live News

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024.

Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review.

Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year.

For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24.

For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY).

Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review.

On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26.

Rainbow Children’s Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds.

During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals

Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.”

Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds.

The scrip slipped 2.60% to Rs 1,347.05 on the BSE.

Powered by Capital Market - Live News

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023.

Powered by Capital Market - Live News

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 9 February 2025.

Powered by Capital Market - Live News